Revvity Total Assets 2010-2025 | RVTY

Revvity total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Revvity total assets for the quarter ending March 31, 2025 were $12.361B, a 7.98% decline year-over-year.
  • Revvity total assets for 2024 were $12.392B, a 8.64% decline from 2023.
  • Revvity total assets for 2023 were $13.565B, a 4% decline from 2022.
  • Revvity total assets for 2022 were $14.13B, a 5.8% decline from 2021.
Revvity Annual Total Assets
(Millions of US $)
2024 $12,392
2023 $13,565
2022 $14,130
2021 $15,001
2020 $7,960
2019 $6,539
2018 $5,976
2017 $6,091
2016 $4,277
2015 $4,166
2014 $4,128
2013 $3,947
2012 $3,902
2011 $3,856
2010 $3,209
2009 $3,059
Revvity Quarterly Total Assets
(Millions of US $)
2025-03-31 $12,361
2024-12-31 $12,392
2024-09-30 $12,770
2024-06-30 $13,425
2024-03-31 $13,433
2023-12-31 $13,565
2023-09-30 $13,422
2023-06-30 $14,219
2023-03-31 $14,638
2022-12-31 $14,130
2022-09-30 $13,824
2022-06-30 $14,190
2022-03-31 $14,848
2021-12-31 $15,001
2021-09-30 $14,900
2021-06-30 $8,739
2021-03-31 $8,763
2020-12-31 $7,960
2020-09-30 $6,866
2020-06-30 $6,637
2020-03-31 $6,384
2019-12-31 $6,539
2019-09-30 $6,489
2019-06-30 $6,399
2019-03-31 $6,086
2018-12-31 $5,976
2018-09-30 $5,862
2018-06-30 $5,958
2018-03-31 $6,126
2017-12-31 $6,091
2017-09-30 $4,739
2017-06-30 $4,605
2017-03-31 $4,341
2016-12-31 $4,277
2016-09-30 $4,305
2016-06-30 $4,194
2016-03-31 $4,211
2015-12-31 $4,166
2015-09-30 $4,032
2015-06-30 $4,083
2015-03-31 $4,028
2014-12-31 $4,128
2014-09-30 $3,886
2014-06-30 $3,937
2014-03-31 $3,971
2013-12-31 $3,947
2013-09-30 $3,852
2013-06-30 $3,811
2013-03-31 $3,808
2012-12-31 $3,902
2012-09-30 $3,890
2012-06-30 $3,801
2012-03-31 $3,864
2011-12-31 $3,856
2011-09-30 $3,402
2011-06-30 $3,596
2011-03-31 $3,306
2010-12-31 $3,209
2010-09-30 $3,248
2010-06-30 $3,146
2010-03-31 $3,027
2009-12-31 $3,059
2009-09-30 $3,059
2009-06-30 $2,946
2009-03-31 $2,858
Sector Industry Market Cap Revenue
Medical Medical Services $11.516B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.850B 26.98
Elevance Health (ELV) United States $84.468B 10.90
CVS Health (CVS) United States $83.959B 10.44
Cencora (COR) United States $56.658B 19.71
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.415B 0.00
Labcorp Holdings (LH) United States $21.653B 17.56
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.432B 0.00
Solventum (SOLV) United States $12.967B 13.73
CochLear (CHEOY) Australia $12.826B 0.00
ICON (ICLR) Ireland $11.783B 10.95
Viatris (VTRS) United States $10.434B 3.58
Avantor (AVTR) United States $9.254B 13.45
HealthEquity (HQY) United States $8.991B 39.38
Medpace Holdings (MEDP) United States $8.943B 23.75
Sonic Healthcare (SKHHY) Australia $8.181B 0.00
Charles River Laboratories (CRL) United States $7.378B 14.46
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.305B 25.35
BrightSpring Health Services (BTSG) United States $3.975B 36.47
Sotera Health (SHC) United States $3.162B 17.97
Surgery Partners (SGRY) United States $2.782B 36.18
Alignment Healthcare (ALHC) United States $2.710B 0.00
Concentras Parent (CON) United States $2.631B 15.21
Organon (OGN) United States $2.600B 2.76
GeneDx Holdings (WGS) United States $2.537B 97.72
PACS (PACS) United States $1.951B 0.00
Ardent Health (ARDT) United States $1.877B 8.00
Premier (PINC) United States $1.799B 13.66
Progyny (PGNY) United States $1.792B 39.45
GoodRx Holdings (GDRX) United States $1.754B 35.07
Teladoc Health (TDOC) United States $1.328B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
Establishment Labs Holdings (ESTA) $1.084B 0.00
CareDx (CDNA) United States $1.064B 16.62
Ryman Healthcare (RYHTY) New Zealand $0.999B 0.00
Agilon Health (AGL) United States $0.902B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.670B 10.14
LifeMD (LFMD) United States $0.584B 0.00
Embecta (EMBC) United States $0.580B 3.91
InnovAge Holding (INNV) United States $0.516B 0.00
Enhabit (EHAB) United States $0.476B 39.17
Auna S.A (AUNA) Luxembourg $0.464B 10.45
Sonida Senior Living (SNDA) United States $0.455B 0.00
Omada Health (OMDA) $0.452B 0.00
SBC Medicals (SBC) United States $0.442B 0.00
Performant Healthcare (PHLT) United States $0.301B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.258B 0.00
Beauty Health (SKIN) United States $0.242B 0.00
Oncology Institute (TOI) United States $0.192B 0.00
So-Young (SY) China $0.189B 0.00
DocGo (DCGO) United States $0.165B 27.00
Pheton Holdings (PTHL) China $0.113B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.095B 0.00
KindlyMD (NAKA) United States $0.085B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
ModivCare (MODV) United States $0.049B 0.00
Biodesix (BDSX) United States $0.040B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00